Probiotics are live microorganisms which, when administered in adequate amounts, confer a health benefit on the host. In contrast to adaptogens, which are compounds of plant origin, probiotics constitute a distinct biological and regulatory category. There are no scientific publications or positions from regulatory institutions that classify probiotics as adaptogens.
A liquid probiotic containing 19 carefully selected bacterial strains works through clearly described physical and biochemical mechanisms occurring in the intestines.
Upon administration, probiotic bacteria attach to the intestinal epithelium, occupying biological space and limiting access for pathogens. Simultaneously, they compete with undesirable microorganisms for nutrients, which inhibits their proliferation. Probiotics also produce short-chain fatty acids (SCFAs), such as lactic acid and butyric acid, which lower the intestinal pH, support the regeneration of the intestinal barrier, and serve as an energy source for enterocytes.
Another important mechanism is the production of bacteriocins—natural substances with antimicrobial activity that directly damage the cell membranes of pathogens. At the same time, probiotics increase the expression of tight junction proteins (including occludin and claudin), sealing the intestinal barrier and limiting the penetration of toxins into the bloodstream.
Probiotics also modulate the immune system, influencing receptors of immune cells in the intestines. The result is the regulation of the inflammatory response and improved production of IgA antibodies. Through metabolites, they also interact with the gut-brain axis, participating in processes related to neurotransmitters such as serotonin and GABA.
The liquid form of the probiotic facilitates the even delivery of bacteria to the gastrointestinal tract and provides a convenient solution for long-term support of intestinal microbiome balance – especially during periods of increased bodily stress.
